Skip to main content
Article
Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy: A Randomized, Controlled Trial
Annals of Internal Medicine (2001)
  • Marc Boogaerts, Katholieke Universiteit Leuven
  • Drew J. Winston, University of California, Los Angeles
  • Eric J. Bow, University of Manitoba
  • Gary Garber, University of Ottawa
  • Annette C. Reboli, University of Medicine and Dentistry of New Jersey
  • Anthony P. Schwarer, Alfred Hospital
  • Nicolas Novitzky
  • Angelika Boehme
  • Elisabeth Chwetzoff
  • Karel De Beule
Publication Date
September 18, 2001
DOI
10.7326/0003-4819-135-6-200109180-00010
Citation Information
Marc Boogaerts, Drew J. Winston, Eric J. Bow, Gary Garber, et al.. "Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy: A Randomized, Controlled Trial" Annals of Internal Medicine Vol. 135 Iss. 6 (2001) p. 412 - 422
Available at: http://works.bepress.com/annette-reboli/44/